1. Home
  2. LIXT vs MVO Comparison

LIXT vs MVO Comparison

Compare LIXT & MVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$5.35

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

MVO

MV Oil Trust Units of Beneficial Interests

HOLD

Current Price

$2.02

Market Cap

26.3M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIXT
MVO
Founded
2005
2006
Country
United States
United States
Employees
3
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
26.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LIXT
MVO
Price
$5.35
$2.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
63.5K
213.8K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
17.46%
EPS Growth
N/A
N/A
EPS
N/A
1.46
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.38
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.97
52 Week High
$6.09
$6.26

Technical Indicators

Market Signals
Indicator
LIXT
MVO
Relative Strength Index (RSI) 67.95 40.34
Support Level $3.77 $1.03
Resistance Level $6.03 $2.42
Average True Range (ATR) 0.63 0.15
MACD 0.05 -0.04
Stochastic Oscillator 82.72 13.83

Price Performance

Historical Comparison
LIXT
MVO

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About MVO MV Oil Trust Units of Beneficial Interests

MV Oil Trust is a statutory trust. The trust was created to acquire and hold the net profits interest for the benefit of the Trust unitholders.

Share on Social Networks: